Traduction de «for the recognition of laboratories » (Néerlandais → Français) :

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

On the other hand, it is advised that the laboratory keep a set of MRSA isolates (minimum 10) from different patients and send it to a reference laboratory for epidemiological typing (genotyping by pulsed-field gel electrophoresis and additional methods as appropriate).
D'autre part, on conseille que le laboratoire garde une série d’isolats de MRSA (au minimum 10) de différents patients et l'envoie à un laboratoire de référence pour le typage épidémiologique (génotypage par électrophorèse de gel à champ pulsé et d’autres méthodes additionnelles si celles-ci s’avèrent utiles).

Het einddoel is om tot een geharmoniseerde toepassing te komen van de inspectienormen binnen de EU en in de landen waarmee een wederzijds erkenningsakkoord (Mutual Recognition Agreement, MRA) afgesloten werd.
L’objectif est de parvenir à une application harmonisée des normes d’inspection au sein de l’UE ainsi que dans les pays avec lesquels un accord de reconnaissance mutuel (Mutual Recognition Agreement, MRA) a été conclu.

De werkgroep is per definitie een meer uitgebreide transversale, interdisciplinaire groep en is samengesteld uit de leden van het projectteam plus leden van Committee for Medicinal Products for Human Use (CHMP), Committee for Advanced Therapies (CAT), Paediatric Committee (PDCO) (inclusief voorzitter), PharmacoVigilance Working Party (PhVWP), Scientific Advice Working Party (SAWP) en Co-ordination Group for Mutual Recognition and Decentralised Procedure, human (CMDh).
Le groupe de travail est par définition un groupe interdisciplinaire et transversal plus large, et se compose des membres de l’équipe de projet plus des membres du Committee for Medicinal Products for Human Use (CHMP), Committee for Advanced Therapies (CAT), Paediatric Committee (PDCO) (y compris le président), PharmacoVigilance Working Party (PhVWP), Scientific Advice Working Party (SAWP) et du Co-ordination Group for Mutual Recognition and Decentralised Procedure, human (CMDh).

Co-ordination Group for Mutual recognition and Decentralised Procedure, human
Co-ordination Group for Mutual recognition and Decentralised Procedures-human

Central to this endeavour are the six key factors which represent the FAMHP’s vision and ambition: ●● Recognition at national, European and international level ●● Developing partnerships with the healthcare
Central to this endeavour are the six key factors which represent the FAMHP’s vision and ambition: ●● Recognition at national, European and international level ●● Developing partnerships with the healthcare

Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission
Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission

In this context, the European Union also has mutual recognition agreements with Australia, New Zealand, Canada, Japan and Switzerland.
In this context, the European Union also has mutual recognition agreements with Australia, New Zealand, Canada, Japan and Switzerland.

Gembloux Agriculural University - GLP Pesticide Science Laboratory (www.fsagx.ac.be)
le GLP Pesticide Science Laboratory de la Faculté universitaire des Sciences Agronomiques de Gembloux (www.fsagx.ac.be)

Gembloux Agriculural University - Laboratory of Ecology ( [http ...]
le Laboratoire d'écologie de la Faculté universitaire des Sciences Agronomiques de Gembloux ( [http ...]